News - Mergers & Acquisitions, Novartis, Sandoz

Filter

Novartis to buy US generic derma company Fougera for over $1.5 billion

03-05-2012

Further expanding its generic drug foot print, Swiss drug giant Novartis (NOVN: VX) is adding to its…

DermatologicalsFougera PharmaceuticalsGenericsMergers & AcquisitionsNovartisPharmaceuticalSandoz

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top